Gerald L. Ray & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$11.1M Buy
174,805
+3,150
+2% +$184K 1.39% 11
2017
Q2
$9.56M Buy
171,655
+2,530
+1% +$138K 1.23% 15
2017
Q1
$9.2M Buy
169,125
+8,340
+5% +$457K 1.26% 17
2016
Q4
$9.4M Buy
160,785
+2,140
+1% +$117K 1.36% 15
2016
Q3
$8.55M Buy
158,645
+26,930
+20% +$1.73M 1.28% 16
2016
Q2
$9.69M Sell
131,715
-533
-0.4% -$37.7K 1.55% 13
2016
Q1
$8.45M Buy
132,248
+665
+0.5% +$41.9K 1.37% 16
2015
Q4
$9.05M Sell
131,583
-850
-0.6% -$56.2K 1.43% 14
2015
Q3
$7.84M Sell
132,433
-350
-0.3% -$22.2K 1.31% 15
2015
Q2
$8.84M Buy
132,783
+1,748
+1% +$115K 1.34% 14
2015
Q1
$8.45M Sell
131,035
-430
-0.3% -$26.9K 1.27% 15
2014
Q4
$7.76M Sell
131,465
-250
-0.2% -$14.1K 1.19% 18
2014
Q3
$6.74M Buy
131,715
+130
+0.1% +$6.49K 1.1% 26
2014
Q2
$6.38M Buy
131,585
+500
+0.4% +$24.6K 1.09% 25
2014
Q1
$6.81M Sell
131,085
-600
-0.5% -$31.9K 1.23% 20
2013
Q4
$7M Buy
131,685
+554
+0.4% +$28.2K 1.32% 19
2013
Q3
$6.07M Sell
131,131
-500
-0.4% -$21.9K 1.26% 20
2013
Q2
$5.88M Buy
+131,631
New +$5.71M 1.32% 20

Other funds holding BMY

Gerald L. Ray & Associates's BMY Position: Q3 2017 in Review

Gerald L. Ray & Associates increased its Bristol-Myers Squibb (BMY) stake by 1.8% in Q3 2017, buying an estimated $184K and bringing the position to 174,805 shares worth $11.1M. The position accounts for 1.39% of the portfolio, ranked #11.

Gerald L. Ray & Associates first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Gerald L. Ray & Associates held 174,805 shares of Bristol-Myers Squibb worth $11.1M as of Q3 2017.
  • Gerald L. Ray & Associates bought 3,150 Bristol-Myers Squibb shares in Q3 2017, an estimated $184K.
  • Bristol-Myers Squibb made up 1.39% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #11 holding.
  • Gerald L. Ray & Associates first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.